Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Monday, 17 July 2017
Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd
Jake Shortt
et al
. published in the
British Journal of Haematology.
Read article
here
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment